Nanotechnology-based drug delivery for central nervous system disorders-Reference-Cited by-同舟云学术

Nanotechnology-based drug delivery for central nervous system disorders

Published:2021-11 Issue: Volume:143 Page:112117
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Nguyen Thuy Trang,Dung Nguyen Thi Thuy,Vo Tuong Kha,Tran Nguyen-Minh-An,Nguyen Minh Kim,Van Vo Toi,Van Vo Giau

Funder

Viet Nam National University Ho Chi Minh City

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference157 articles.

1. G.B.D.N. Collaborators, Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol 18(5) (2019) 459–480.

2. Gene panels and primers for next generation sequencing studies on neurodegenerative disorders;Van Giau;Mol. Cell. Toxicol.,2015

3. , Nanomedicine-based immunotherapy for central nervous system disorders;Hanif;Acta Pharmacol. Sin.,2020

4. Recent progress of nanomedicine in the treatment of central nervous system;Feng;Adv. Ther.,2020

5. Advances in developing therapeutic strategies for Alzheimer’s disease;Nguyen;Biomed. Pharmacother.,2021

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases;Current Drug Delivery;2024-08

2. Research progress in brain-targeted nasal drug delivery;Frontiers in Aging Neuroscience;2024-01-17

3. Multifunctional Nanotheranostics for Overcoming the Blood–Brain Barrier;Advanced Functional Materials;2024-01-04

4. PLGA mediated drug delivery for Alzheimer's disease;Alzheimer's Disease and Advanced Drug Delivery Strategies;2024

5. Neuroprotection through nanotechnology;Natural Molecules in Neuroprotection and Neurotoxicity;2024